Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Qiagen NV QGEN

Technology Scientific & Technical Instruments
Qiagen NV is a holding company based in the Netherlands. The Company is engaged in providing Sample to Insight solutions that transform biological samples into molecular insights. Its Sample to Insight solutions integrate sample and assay technologies, bioinformatics and automation systems. Its sample technologies are used for isolating and preparing deoxyribonucleic acid (DNA), ribonucleic... see more

Recent & Breaking News (NYSE:QGEN)

QIAGEN launches novel tools for customizing digital PCR assays and NGS panels for microbial analysis

GlobeNewswire 10 hours ago

QIAGEN collaborates with McGill University to advance microbiome research

GlobeNewswire November 12, 2024

QIAGEN delivers solid Q3 2024 growth ahead of outlook, increases full-year 2024 adjusted EPS outlook

GlobeNewswire November 6, 2024

QIAGEN receives FDA clearance of QIAstat-Dx meningitis/encephalitis panel to support emergency diagnostics

GlobeNewswire November 4, 2024

QIAGEN receives FDA clearance for QIAstat-Dx mini panel to improve precision in outpatient respiratory treatment

GlobeNewswire October 29, 2024

QIAGEN expands automated liquid biopsy portfolio to enhance oncology, prenatal care and organ transplant applications

GlobeNewswire October 10, 2024

QIAGEN N.V. to release results for Q3 2024 and hold webcast

GlobeNewswire October 10, 2024

Global TB Summit 2024: QIAGEN leads the charge as tuberculosis reemerges as a leading infectious killer

GlobeNewswire October 7, 2024

QIAGEN launches QIAcuityDx digital PCR system for clinical testing in oncology

GlobeNewswire September 30, 2024

QIAGEN receives European IVDR certification for QIAstat-Dx syndromic testing instruments and assays

GlobeNewswire September 26, 2024

PreAnalytiX, a QIAGEN and BD joint venture, launches novel solution for liquid biopsy from urine samples

GlobeNewswire September 25, 2024

QIAGEN and Bode Technology partner to advance use of GEDmatch PRO forensic genetic genealogy database

GlobeNewswire September 23, 2024

QIAGEN expands QIAcuity digital PCR offering with over new 100 assays via GeneGlobe platform

GlobeNewswire September 18, 2024

QIAGEN and Bio-Manguinhos/Fiocruz collaborate to enhance malaria and dengue detection in Brazil's national screening programs

GlobeNewswire September 12, 2024

QIAGEN and Lilly collaborate to support development of a QIAstat-Dx IVD panel that identifies patients at risk for developing Alzheimer's disease

GlobeNewswire September 4, 2024

QIAGEN expands QIAstat-Dx into precision medicine through partnership for companion diagnostics in chronic diseases

GlobeNewswire August 28, 2024

Myriad Genetics Reports Strong Second Quarter 2024 Financial Results, including 15% Revenue Growth Year-Over-Year; Raises 2024 Financial Guidance and Long-Term Revenue Growth Target to 12%

GlobeNewswire August 6, 2024

QIAGEN delivers solid performance and exceeds outlook for Q2 2024

GlobeNewswire July 31, 2024

QIAGEN to enhance the identification of human remains of Indigenous people and African Americans

GlobeNewswire July 8, 2024

QIAGEN N.V. to release results for Q2 2024 and hold webcast

GlobeNewswire July 2, 2024